Howard Hughes Medical Institute, Boston Children's Hospital, Boston, MA 02115.
Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115.
Proc Natl Acad Sci U S A. 2017 Aug 8;114(32):8614-8619. doi: 10.1073/pnas.1709203114. Epub 2017 Jul 26.
Variable regions of Ig chains provide the antigen recognition portion of B-cell receptors and derivative antibodies. Ig heavy-chain variable region exons are assembled developmentally from V, D, J gene segments. Each variable region contains three antigen-contacting complementarity-determining regions (CDRs), with CDR1 and CDR2 encoded by the V segment and CDR3 encoded by the V(D)J junction region. Antigen-stimulated germinal center (GC) B cells undergo somatic hypermutation (SHM) of V(D)J exons followed by selection for SHMs that increase antigen-binding affinity. Some HIV-1-infected human subjects develop broadly neutralizing antibodies (bnAbs), such as the potent VRC01-class bnAbs, that neutralize diverse HIV-1 strains. Mature VRC01-class bnAbs, including VRC-PG04, accumulate very high SHM levels, a property that hinders development of vaccine strategies to elicit them. Because many VRC01-class bnAb SHMs are not required for broad neutralization, high overall SHM may be required to achieve certain functional SHMs. To elucidate such requirements, we used a V(D)J passenger allele system to assay, in mouse GC B cells, sequence-intrinsic SHM-targeting rates of nucleotides across substrates representing maturation stages of human VRC-PG04. We identify rate-limiting SHM positions for VRC-PG04 maturation, as well as SHM hotspots and intrinsically frequent deletions associated with SHM. We find that mature VRC-PG04 has low SHM capability due to hotspot saturation but also demonstrate that generation of new SHM hotspots and saturation of existing hotspot regions (e.g., CDR3) does not majorly influence intrinsic SHM in unmutated portions of VRC-PG04 progenitor sequences. We discuss implications of our findings for bnAb affinity maturation mechanisms.
Ig 链的可变区提供了 B 细胞受体和衍生抗体的抗原识别部分。Ig 重链可变区外显子在发育过程中由 V、D、J 基因片段组装而成。每个可变区包含三个抗原结合互补决定区(CDR),CDR1 和 CDR2 由 V 片段编码,CDR3 由 V(D)J 连接区编码。抗原刺激的生发中心(GC)B 细胞经历 V(D)J 外显子的体细胞超突变(SHM),然后选择增加抗原结合亲和力的 SHM。一些感染 HIV-1 的人类受试者会产生广泛中和抗体(bnAbs),例如强效的 VRC01 类 bnAbs,能够中和多种 HIV-1 株。成熟的 VRC01 类 bnAbs,包括 VRC-PG04,积累了非常高的 SHM 水平,这一特性阻碍了开发能够诱导产生它们的疫苗策略。由于许多 VRC01 类 bnAb 的 SHM 对于广泛中和不是必需的,因此实现某些功能的 SHM 可能需要较高的总体 SHM 水平。为了阐明这些要求,我们使用 V(D)J 乘客等位基因系统在小鼠 GC B 细胞中检测代表人类 VRC-PG04 成熟阶段的底物中的核苷酸的序列内在 SHM 靶向率。我们确定了 VRC-PG04 成熟的限速 SHM 位置,以及与 SHM 相关的 SHM 热点和内在频繁缺失。我们发现,由于热点饱和,成熟的 VRC-PG04 的 SHM 能力较低,但也证明了在 VRC-PG04 前体序列未突变部分中,产生新的 SHM 热点和现有热点区域(例如,CDR3)的饱和不会主要影响内在 SHM。我们讨论了我们的发现对 bnAb 亲和力成熟机制的影响。